MAYNE PHARMA INC FDA Approval ANDA 207313

ANDA 207313

MAYNE PHARMA INC

FDA Drug Application

Application #207313

Application Sponsors

ANDA 207313MAYNE PHARMA INC

Marketing Status

Prescription001

Application Products

001CAPSULE;ORAL300MG;50MG0BUTALBITAL AND ACETAMINOPHENACETAMINOPHEN; BUTALBITAL

FDA Submissions

UNKNOWN; ORIG1AP2017-12-27STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAA

CDER Filings

MAYNE PHARMA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 207313
            [companyName] => MAYNE PHARMA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"BUTALBITAL AND ACETAMINOPHEN","activeIngredients":"ACETAMINOPHEN; BUTALBITAL","strength":"300MG;50MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"Yes"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"12\/27\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-12-27
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.